skip to content

Supply Chain Integrity (UTHSC)

UTHSC’s APEC Supply Chain Integrity CoE Pilot Program



Ilisa Bernstein

  • Ilisa BernsteinDeputy Director,
    Center for Drug Evaluation and Research,
    Office of Compliance,
    U.S. Food and Drug Administration (U.S. FDA)
    • Day2> Morning Session
      • The APEC Supply Chain Security Roadmap and Center of Excellence
    • Day2> Afternoon Session
      • Supply Chain Security Strategies (Regulatory Perspective)
    • Day4> Morning Session
      • Regulatory Monitoring and Surveillance Programs
    • Day4> Afternoon Session (Moderator)

Michael Cummins

  • Michael CumminsSenior Operations Manager/ Special Agent,
    Office of Criminal Investigations
    U. S. Food and Drug Administration (U.S. FDA)
    • Day 3> Morning Session
      • Preventing Product Diversion
    • Day 4> Morning Session (Moderator)
    • Day 4> Morning Session
      • Marketplace Surveillance and Criminal Investigation Programs

Katharine (Katie) Neckers

  • Katharine (Katie) NeckersRegulatory Counsel,
    Office of Drug Security, Integrity & Response,
    U. S. Food and Drug Administration (U.S. FDA)
    • Day 2> Afternoon Session (Moderator)
    • Day 3> Morning Session (Moderator)

Anthony Orme

  • Anthony OrmeSenior GDP Inspector,
    UK Medicine and Healthcare Products Regulator Agency
    (MHRA)
    • Day 3> Morning Session
      • Intersection of GDP’s and Product Security

Rocio Delgado Montero

  • Rocio Delgado MonteroInternational Coordinator,
    DIGEMID
    • Day 2> Morning Session
      • Falsified Medicines Case Studies (Regulator Perspective)

Charles Grinstead

  • Charles GrinsteadAssistant Special Agent in Charge,
    Kansas City Field Office
    U. S. Food and Drug Administration (U.S. FDA)
    • Day 2> Morning Session
      • Falsified Medicines Case Studies (Regulator Perspective)

Tia Harper Velasquez

  • Tia Harper VelasquezCaptain,
    United States Public Health Service Branch chief,
    Supply Chain Strategy & Policy Branch,
    Division of Supply Chain Integrity,
    U. S. Food and Drug Administration (U.S. FDA)
    • Day 3> Morning Session
      • Industry and Regulator Notification Systems
    • Day 4> Morning Session
      • Mitigating Supply Chain Theft

Brian Johnson

  • Brian JohnsonSenior Director,
    Supply Chain Security,
    Pfizer Inc.
    • Day 2> Morning Session (Moderator)
    • Day 2> Afternoon Session
      • Supply Chain Security Strategies (Industry Perspective)
    • Day 3> Morning Session
      • Industry and Regulator Notification Systems

Antony Zook

  • Antony ZookExecutive Director,
    Product Integrity,
    Merck
    • Day 2> Morning Session
      • Falsified Medicines Case Studies (Industry Perspective)
    • Day 2> Afternoon Session
      • Supply Chain Security Strategies (Industry Perspective)
    • Day 3> Morning Session
      • Preventing Product Diversion
    • Day 4> Morning Session
      • Marketplace Surveillance and Criminal Investigation Programs

Rich Kaeser

  • Rich Kaeser Vice President,
    Global Brand Protection,
    Johnson & Johnson
    • Day 2> Morning Session
      • Falsified Medicines Case Studies (Industry Perspective)
    • Day 2> Afternoon Session
      • Supply Chain Security Strategies (Industry Perspective)

David Ulrich

  • David UlrichQA Director,
    Supply Chain Compliance,
    AbbVie Inc.
    • Day 3> Morning Session
      • Intersection of GDP’s and Product Security
    • Day 3> Afternoon Session (Moderator)

Claudio Mendez

  • Claudio MendezOperation Executive
    Pharmed Pharmaceuticals
    • Day 3> Morning Session
      • Supply Chain Academy/Rx-360 Training Programs

Tony Strange

  • Tony Strange Director,
    Global Brand Protection, Pharmaceuticals,
    Johnson & Johnson
    • Day 3> Morning Session
      • Preventing Product Diversion

Lee Spach

  • Lee SpachDirector,
    Global Product & Supply Chain Security
    Biogen
    • Day 4> Morning Session
      • Mitigating Supply Chain Theft

Kennard Brown

  • Kennard BrownExecutive Vice Chancellor and Chief Operations Officer
    University of Tennessee Health Science Center (UTHSC)
    • Day 1> UTHSC Welcome
    • Day 4> Closing Plenary Session

Ernest Nichols

  • Ernest NicholsAssociate Professor of Supply Chain Management
    Department of Marketing & Supply Chain Management
    University of Memphis
    • Day 3> Keynote Speech
      • Improving Performance in Pharmaceutical Supply Chains

Harry Kochat

  • Harry Kochat Director,
    Plough Center Pharmaceutical Manufacturing & Business Development,
    University of Tennessee Health Science Center (UTHSC)
    • Day 4> Keynote Speech
      • An Overview of Quality Compliant Rd2Rx Track & Trace Approach for Drug Supply Chain Security Management

Mick Deats

  • Mick DeatsGroup Lead,
    SSFFC Medical Products
    Safety and Vigilance
    Essential Medicines and Health Products,
    World Health Organization (WHO)
    • Day 2> Morning Session
      • Falsified Medicines Case Studies (Regulator Perspective)
    • Day 2> Afternoon Session
      • Supply Chain Security Strategies (Regulatory Perspective)
    • Day 2> Supply Chain Security Strategies Case Study
    • Day 4> Morning Session
      • Regulatory Monitoring and Surveillance Programs
    • Day 4> Afternoon Session (Moderator)

Mark Paxton

  • Mark PaxtonCEO
    RX 360
    • Day 3> Morning Session (Moderator)